or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    CRVO F CervoMed Inc. -0.62
    INMB F INmune Bio Inc. 4.39
    BDTX F Black Diamond Therapeutics, Inc. 0.00
    ADAP F Adaptimmune Therapeutics plc -4.23
    CATX F Perspective Therapeutics, Inc. -51.38
    BNOX F Bionomics Limited -1.56
    MBIO F Mustang Bio, Inc. -0.53
    PPBT F Purple Biotech Ltd. 2.83
    SNGX F Soligenix, Inc. -4.27
    MTEM F Molecular Templates, Inc. -2.06
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Biopharmaceutical Immune System Immunotherapy Radiation Solid Tumors Antineoplastic Drugs Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Checkpoint Inhibitor Epidermal Growth Factor Receptor Immunotherapy Products Non Small Cell Lung Cancer Oncology Oxygen Radiation Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.54
    SBIO C ALPS Medical Breakthroughs ETF 1.56
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.55
    CANC D Tema Oncology ETF 1.44
    MEDX F Horizon Kinetics Medical ETF 0.98
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare CNCR to CANC Compare CNCR to MEDX Compare CNCR to SBIO

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 21 CATX Perspective slips after Phase 1/2 trial data for radio pharma drug
        Nov 21 CATX Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
        Nov 18 BNOX Bionomics files for $100M mixed securities shelf
        Nov 16 ADAP Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 CATX Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025?
        Nov 15 CATX Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Solid Tumors Biotechnology Clinical Medicine Immune System Immunotherapy Biopharmaceutical Immunology Monoclonal Antibody Ovarian Cancer Immunotherapies Life Sciences Monoclonal Antibodies Treatment Of Cancer Virotherapy Acute Myeloid Leukemia Antibodies Antibody Drug Conjugate Antineoplastic Drugs
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags